• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Diagn Microbiol Infect Dis . Impact of RNA degradation on influenza diagnosis in the surveillance system

tetano

Editor, Senior Moderator
Diagn Microbiol Infect Dis


. 2021 May 21;100(4):115388.
doi: 10.1016/j.diagmicrobio.2021.115388. Online ahead of print.
Impact of RNA degradation on influenza diagnosis in the surveillance system


Hongyan Bai[SUP] 1 [/SUP], Jiashen Zhao[SUP] 2 [/SUP], Chunyan Ma[SUP] 2 [/SUP], Hejiang Wei[SUP] 1 [/SUP], Xiyan Li[SUP] 1 [/SUP], Qiongqiong Fang[SUP] 1 [/SUP], Peng Yang[SUP] 2 [/SUP], Quanyi Wang[SUP] 2 [/SUP], Dayan Wang[SUP] 1 [/SUP], Li Xin[SUP] 3 [/SUP]



Affiliations

Abstract

Background: The continuous evolution of influenza viruses is monitored by the World Health Organization Global Influenza Surveillance and Response System. Sample quality is essential for surveillance quality.
Methods: To evaluate the RNA degradation of clinical samples, influenza-like illness samples were collected from four sentinel hospitals, and seasonal influenza was tested by real-time reverse transcription polymerase chain reaction and quantified by digital reverse transcription polymerase chain reaction at different time points.
Results: RNA degradation was observed in the majority of samples eight days after sample collection. A significant and faster rate of RNA content reduction was observed in low viral load samples (<10 copies/µl) than in high viral load samples (>10 copies/μl), stored at 2 to 8°C for up to eight days. RNase P (RNP) RNA, which is a key indicator to evaluate sample collection quality, was detected. Sample collection quality was uneven in different hospitals.
Conclusion: Low viral load samples increase the risk of false negatives due to RNA degradation to undetectable levels.

Keywords: Influenza; RNA degradation; Sample quality; Surveillance.
 
Back
Top Bottom